Table 2.
Summary of the observations made on the influence of demographical factors.
| Demographical considerations | Group | N | In accordance with previous works |
|---|---|---|---|
| NcirDNA concentration | |||
| A statistical difference between males and females | Healthy | 104 | Catarino R, et al.63 |
| No statistical difference between males and females | mCRC | 118 | Hao TB, et al.31 |
| A statistical difference with regard to age | Healthy | 104 | Jylhävä J, et al.35 |
| No statistical difference with regard to age | mCRC | 118 | Van der Drift MA, et al.30 |
| Statistical increase in mCRC patients as compared to healthy individuals | Healthy mCRC |
104 118 |
Bedin C, et al.64 |
| McirDNA concentration | |||
| No statistical difference between males and females | Healthy mCRC |
104 50 |
New observation |
| No statistical difference with regard to age | Healthy mCRC |
104 50 |
Jylhävä J, et al.35 New observation |
| Statistical decrease in mCRC patients as compared to healthy individuals | Healthy mCRC |
104 50 |
New observation |
| McirDNA vs NcirDNA concentration | |||
| Necessity of independently quantifying NcirDNA and McirDNA | |||
| About 50,000-fold more McirDNA copy number as compared to NcirDNA in healthy individuals | Healthy | 104 | New observation |
| About 3,000-fold more McirDNA copy number as compared to NcirDNA in cancer patients | mCRC | 50 | New observation |
| About 20-fold more McirDNA/NcirDNA ratio in healthy individuals as compared to mCRC patients | Healthy mCRC |
104 50 |
New observation |